We have examined the literature to identify genes most frequently hypermethylated in NSCLC, which led us to the investigation of the genes HOXA9 and SOX1 that have shown potential as diagnostic and prognostic biomarkers in NSCLC [11,12]. The gene discussed is HOXA9; the disease is non-small cell lung carcinoma.